Search results
Editas (EDIT) Stock Gains 23% in the Past 6 Months: Here's Why
Zacks via Yahoo Singapore Finance· 6 months agoEditas (EDIT) shares have gained 23% in the past six months, driven by encouraging findings from the...
CRISPR and other new technologies open doors for drug development, but which diseases get...
The Conversation via Yahoo News Singapore· 7 months agoDrug development takes a great deal of time, money and effort. While future profits play a big...